Results 131 to 140 of about 18,744,545 (170)
In Vivo Synaptic Density Imaging with 11C-UCB-J Detects Treatment Effects of Saracatinib in a Mouse Model of Alzheimer Disease. [PDF]
Toyonaga T +11 more
europepmc +1 more source
A new phenylstannyl precursor for synthesizing [11C]UCB-J
openaire +1 more source
Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging. [PDF]
Filippi L, Nuvoli S, Spanu A, Palumbo B.
europepmc +1 more source
Building an open infrastructure for molecular neuroimaging: Standards and tools from the OpenNeuroPET initiative. [PDF]
Ganz M +19 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain
Molecular Imaging and Biology, 2020Purpose: Loss of neuronal synapse function is associated with a number of brain disorders. The [11C]UCB-J positron emission tomography (PET) tracer allows for in vivo examination of synaptic density, as it binds to synaptic vesicle glycoprotein 2A (SV2A) expressed in presynaptic terminals.
Betina Elfving +2 more
exaly +4 more sources
Principal component analysis of synaptic density measured with [11C]UCB-J PET in Alzheimer's disease
The American Journal of Geriatric Psychiatry, 2021Introduction Synaptic loss has been cited as an early pathological event and major structural correlate of cognitive impairment in Alzheimer's disease (AD). However, this observation is based on limited neuropathological studies. Here, we examined the in vivo relationship between synaptic density and cognitive performance in early AD using [11C]UCB-J ...
Ryan O'Dell +17 more
openaire +1 more source

